Accolade to Acquire 2nd.MD
Accolade to Acquire 2nd.MD
14 janv. 2021 16h50 HE | Accolade, Inc.
The addition of 2nd.MD’s Expert Medical Opinion services to Accolade’s portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade’s clinical capabilities and creates...
Accolade_logo_Press Release.png
Accolade to Participate in 39th Annual J.P. Morgan Healthcare Conference
11 janv. 2021 08h00 HE | Accolade, Inc.
SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade_logo_Press Release.png
Accolade Announces Results for Fiscal Third Quarter 2021
07 janv. 2021 16h05 HE | Accolade, Inc.
Fiscal third quarter 2021 revenue of $38.4 million, a 30% increase compared to fiscal third quarter 2020 revenue of $29.7 million, driven primarily by strength in new customer additions across market...
Accolade_logo_Press Release.png
Accolade to Announce Fiscal Third Quarter 2021 Financial Results
23 déc. 2020 08h00 HE | Accolade, Inc.
SEATTLE, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade_logo_Press Release.png
Accolade to Participate in William Blair Healthcare 2021 Focus List Event
17 déc. 2020 05h00 HE | Accolade, Inc.
SEATTLE, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade_logo_Press Release.png
Accolade to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
20 nov. 2020 08h00 HE | Accolade, Inc.
SEATTLE, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade_logo_Press Release.png
Accolade to Participate in the 29th Annual Credit Suisse Healthcare Conference
28 oct. 2020 08h30 HE | Accolade, Inc.
SEATTLE, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade_logo_Press Release.png
Accolade Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
26 oct. 2020 16h05 HE | Accolade, Inc.
SEATTLE, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade_logo_Press Release.png
Accolade Announces Pricing of Public Offering of Common Stock
21 oct. 2020 23h57 HE | Accolade, Inc.
SEATTLE, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade_logo_Press Release.png
Accolade Announces Proposed Public Offering of Common Stock
19 oct. 2020 16h28 HE | Accolade, Inc.
SEATTLE, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...